ライフサイエンスコーパス: albumin

1 on with a CCD inhibitor (MUXF(3)-human serum albumin).

2 chanism even in the presence of low doses of albumin.

3 h circulating concentrations of both IgG and albumin.

4 trypsin inhibitor-1) and a heterodimeric 2S albumin.

5 articipants received supportive therapy with albumin.

6 matography based purification of human serum albumin.

7 removed, yielding fully mature heterodimeric albumin.

8 peptides from trypsin digested bovine serum albumin.

9 ng plays a main role in the binding of SA to Albumin.

10 echanism even after exposure to low doses of albumin.

11 ding albumin variant compared with wild-type albumin.

12 ells and does not interact with bovine serum albumin.

13 ifact of acetic acid-mediated degradation of albumin.

14 d microvessel permeability to both water and albumin.

15 ntrols and was detected earlier than urinary albumin.

16 ding pathway for a group of homologous serum albumins.

17 Alexa-Albumin 647 nm fluorphore was chosen as a surrogate for

18 Albumin accumulation in early endosomes was independent

19 gnificant increase in albumin oxidation, and albumin acts as a pro-oxidant; this promotes oxidative s

20 Analysis of rates and predictors of albumin administration, and estimated costs.

21 hat both small molecules were able to confer albumin affinity to GLP-1 and indicated that affinity is

22 intracelluar uptake of fluorescently labeled albumin after intradermal injection by LECs was similar

23 stigating the advanced glycation end-product-albumin (AGE-albumin) from activated macrophages is crit

24 using electrospun amyloid like-bovine serum albumin (AL-BSA) nanofibers on QCM surfaces.

25 efining certain secretory cellular lineages: albumin (ALB) in liver carcinoma, gastric lipase (LIPF)

26 Albumin/AlbiVax nanocomplexes are thus a robust platform

27 biVax), here we develop clinically promising albumin/AlbiVax nanocomplexes that self-assemble in vivo

28 G and antigens (Ags) to lymph nodes (LNs) by albumin/AlbiVax than benchmark incomplete Freund's adjuv

29 s index, haemoglobin, serum uric acid, serum albumin, albuminuria, and C reactive protein as non-GFR

30 Albumin also stimulated an epithelial-mesenchymal transi

31 herent property to interact selectively with albumin among different biomolecules in intracellular en

32 maturation of sunflower proalbumins into an albumin and a macrocyclic peptide.

33 These data, demonstrating that albumin and calcium act synergistically in the host envi

34 ularly notable is the strong upregulation of albumin and fibrinogen genes, which suggest significant

35 s were found in the relationship of glycated albumin and fructosamine levels with the mean glucose co

36 a model that low levels of HBsAg, HBcAb, and albumin and high fibrosis values predicted strong antivi

37 r (NCC) by forming tripartite complexes with albumin and increasing biliary copper excretion.

38 uation of Cav-1 expression reduced uptake of albumin and nab-paclitaxel in cancer cells and rendered

39 teine, homocysteine, glutathione, quercetin, albumin and tannic reduce bioavailability of both mercur

40 f lipid binding to the soluble protein serum albumin and to the integral membrane protein NapA shows

41 recycling and bidirectional transcytosis of albumin and uniquely determines the physiologic release

42 g white, whole egg, defatted egg yolk, wheat albumins and wheat globulins were detected.

43 d hemoglobin (HbA1c), fructosamine, glycated albumin), and a latent variable for kidney function (cre

44 which cause hypoalbuminemia, biliary loss of albumin, and increased intracellular accumulation of alb

45 cs, clinical characteristics, comorbidities, albumin, and residual kidney function).

46 re, kidney weight/body weight ratio, urinary albumin, and urinary thiobarbituric acid-reacting substa

47 the covalent immobilization of bovine serum albumin antibody (anti-BSA) and fibrinogen antibody (ant

48 ucture of PawS1 revealed that SFTI-1 and the albumin are independently folded into well-defined domai

49 agmatic clinical trials of terlipressin with albumin are warranted to evaluate real-world effectivene

50 ging the long-lived endogenous serum protein albumin as an siRNA carrier.

51 PS (n = 29) or large-volume paracenteses and albumin as necessary (LVP+A, n = 33).

52 We have found that albumin, as a model for biocorona-forming macromolecules

53 Presence of human albumin at physiologic concentration in the culture medi

54 for the response to nab-paclitaxel and other albumin-based cancer therapeutic drugs.

55 with an antibody response against the human albumin-based carrier protein, which was prevented by us

56 rotein, which was prevented by using a mouse albumin-based equivalent (pPB-MSA).

57 This work examines the use of serum-albumin-based freestanding mats as macroscopic electron

58 undiluted serum than Abraxane, a commercial albumin-based PTX nanoparticle formulation, while mainta

59 lbumin recycling and the possibility to tune albumin-based therapeutic effects by FcRn-binding affini

60 Baseline level of albumin below 3.5 g/dL was the only negative factor asso

61 Four markers (albumin, beta-2-microglobulin, cystatin C, and osteopont

62 supercharging was probed using bovine serum albumin, beta-lactoglobulin, and lysozyme, each of which

63 New albumin, bilirubin, and alkaline phosphatase grade 3/4 t

64 prognosticators on univariate analysis were albumin, bilirubin, ascites, tumor size 5 cm or smaller,

65 Purpose To construct a nomogram with the albumin-bilirubin (ALBI) grade to assess the long-term o

66 e effect of mono- or divalent small-molecule albumin binders for half-life extension of peptides.

67 the renal excretion kinetic and intrahepatic albumin binding affinity of CyG can further be used to d

68 tion was proportional to FcRn expression and albumin-binding affinity.

69 umor-specific delivery of amphiphile-CpG, an albumin-binding analog of CpG ODN, following systemic ad

70 The engineered albumin-binding domain-derived affinity protein (ADAPT)

71 molecular vaccines with Evans blue (EB) into albumin-binding vaccines (AlbiVax), here we develop clin

72 which lies in Subdomain IIIA of human serum albumin, blocks binding of all three antibodies to nab-p

73 patients resulted in a temporary increase in albumin blood level and symptom improvement in 1 patient

74 R) of imiquimod in combination with systemic albumin bound paclitaxel in treatment-refractory breast

75 emoimmunomodulation with a TLR-7 agonist and albumin bound paclitaxel is effective in inducing diseas

76 Albumin bound paclitaxel, 100 mg/m2, was given intraveno

77 Abraxane(R), the albumin bound PTX, represents a superior replacement of

78 on, but they also enhance sensitivity to the albumin-bound hepatotoxin, acetaminophen (APAP).

79 A parsimonious mechanism involves leakage of albumin-bound nonesterified fatty acids (NEFAs) across t

80 Bovine serum albumin (BSA) adsorption was studied at different pHs an

81 Bovine serum albumin (BSA) and dextran varying in molecular weights w

82 ically relevant components like bovine serum albumin (BSA) and lipopolysaccharide.

83 comprising alternate layers of bovine serum albumin (BSA) and tannic acid (TA) were tested as Lf enc

84 gold nanoclusters (AuNCs) using bovine serum albumin (BSA) as a protecting agent.

85 dodecyl maltoside (DDM) protect bovine serum albumin (BSA) from unfolding in SDS.

86 echanism of SA interaction with bovine serum albumin (BSA) has been investigated by multi-spectroscop

87 ration of fluorescently labeled bovine serum albumin (BSA) into the nanoslits; and fluorescence corre

88 ay; LC-MS of a trypsin-digested bovine serum albumin (BSA) sample provided narrow peaks, short dwell

89 patible nanocomposite including bovine serum albumin (BSA) template Cu nanoclusters (CuNCs@BSA) and s

90 nstrated that the adsorption of bovine serum albumin (BSA) to aqueous gold colloids can be quantified

91 the heat denaturation degree of bovine serum albumin (BSA) was assessed.

92 eraction between Allura Red and bovine serum albumin (BSA) was studied in vitro at pH 7.4.

93 lized via EDC-NHS chemistry and Bovine serum albumin (BSA) was used for blocking of the non-specific

94 llowed by a post-treatment with bovine serum albumin (BSA) which served as the blocking agent to prev

95 nhibitor (TI); Ovalbumin (OVA); Bovine Serum Albumin (BSA)), we observe resolution of the markers in

96 red to Y-tube compartments with bovine serum albumin (BSA), GDNF and NGF increased the motor and sens

97 ted gold film and adsorption of bovine serum albumin (BSA), respectively, on poly(methyl methacrylate

98 Bovine serum albumin (BSA), whey protein isolate (WPI), insulin and a

99 ulated biothreat scenario using bovine serum albumin (BSA).

100 red from inherent biocompatible bovine serum albumin (BSA).

101 rization from the model protein bovine serum albumin (BSA).

102 Bovine serum albumin (BSA)/curcumin binding and dye photodegradation

103 circuits altering the binding capacities of albumin by biochemical (changing of pH) and physical (ch

104 provides rapid regeneration of toxin-binding albumin by two purification circuits altering the bindin

105 Mean levels of albumin, calcium, iron, ferritin, cholesterol, vitamin B

106 r studies are required to confirm that serum albumin can be used as a biomarker to monitor disease ac

107 ng intranasal house dust mite or aerosol ova-albumin challenge, and chloroquine or quinine were teste

108 m containing Pluronic F-127 then coated with albumin ("Cim-F-alb") had the smallest size and the most

109 o overcome these challenges, we developed an albumin-coated nanocrystal (NC) formulation of paclitaxe

110 Increasing albumin concentration was also found to reduce dissoluti

111 osis on initial biopsy as well as age, serum albumin concentration, and CKD stage at onset affected E

112 erum total cholesterol, LDL cholesterol, and albumin concentrations.

113 e mice, and we demonstrate that breakdown of albumin contributes to the supply of free amino acids in

114 Total estimated albumin cost significantly increased from $325 million i

115 hep) mice) by crossing Hoip-floxed mice with albumin-Cre mice.

116 digests of three model proteins (Human Serum Albumin, creatine kinase, and myoglobin).

117 ertension (P < 0.001), the increase of urine albumin creatinine ratio (P < 0.01), the fall in glomeru

118 eGFR <60 mL.min(-1).1.73 m(-2) and/or urine albumin-creatinine ratio >300 mg/g) at baseline.

119 90 mL.min(-1).1.73 m(-2)) and baseline urine albumin-creatinine ratio (>300, 30-</=300, <30 mg/g).

120 nsistent across categories of eGFR and urine albumin-creatinine ratio at baseline and across the 2 do

121 ation rate <60 mL/min per 1.73 m(2) or urine albumin/creatinine >30 mg/g) and available echocardiogra

122 ic acid clearance) was associated with urine albumin/creatinine ratio (UACR) post-HTx in a subgroup o

123 ructural renal lesions, and measured urinary albumin/creatinine ratios, tissue oxidative stress level

124 l attenuated CS-induced increases in urinary albumin/creatinine ratios, tissue oxidative stress level

125 ed renal function was determined via urinary albumin/creatinine-ratio (uACR).

126 n (PGRP) were not detected while camel serum albumin (CSA) was significantly diminished.

127 Transplant albumin, day-1 aspartate aminotransferase (AST), day-1 l

128 ese properties allow hepatic FcRn to mediate albumin delivery and maintenance in the circulation, but

129 regarding the virulence of P. aeruginosa in albumin-depleted versus albumin-rich infection sites and

130 egies to overcome the pitfall of present day albumin detection methods as well as accelerate the dete

131 anced Organ Support (ADVOS) is a new type of albumin dialysis, that provides rapid regeneration of to

132 We also deliver albumin directly into tumors using an implantable microd

133 inding affinities significantly affected the albumin distribution between late endosomes and lysosome

134 nsely immobilized conjugates of bovine serum albumin (DNP-BSA) or mobile in a supported lipid bilayer

135 nomenon, serum collected from mice that lack albumin does not stimulate an increase in ACT.

136 el based on its similar molecular weight and albumin driven pharmacokinetics.

137 for a possible role of the CUBAM complex in albumin endocytosis in human podocytes.

138 The albumin endocytosis is Ca(2+)-dependent and accompanied

139 ormoalbuminuric or macroalbuminuric (urinary albumin excretion <30 mg/24 hours and >300 mg/24 hours,

140 xture to identify associations between urine albumin excretion (urine albumin-to-creatinine ratio [UA

141 dies have found an association between urine albumin excretion and Amerindian ancestry in Hispanic/La

142 as lost after further adjustment for urinary albumin excretion and eGFR [HR:1.15 (95% CI, 0.81-1.64),

143 nts with type 1 diabetes, rapid increases in albumin excretion during puberty precede the development

144 variants influencing the variation of urine albumin excretion in Hispanics/Latinos.

145 hesized that adolescents with high levels of albumin excretion might benefit from angiotensin-convert

146 In incipient nephropathy, when albumin excretion rates are abnormal, proteomic/peptidom

147 om podocytes exhibited an elevation in urine albumin excretion that was accompanied by increased podo

148 GC-A cKO mice demonstrated increased urinary albumin excretion with marked mesangial expansion, podoc

149 ng-term benefits of empagliflozin on urinary albumin excretion, irrespective of patients' albuminuria

150 duced systolic blood pressure (SBP), urinary albumin excretion, segmental sclerosis, podocyte injury,

151 anoparticle conjugate of paclitaxel to human albumin, exhibits efficacy in pancreatic cancer, non-sma

152 Our findings provide insights on how albumin extravasation that occurs upon BBB dysfunction i

153 d confirm Evans blue (bound to macromolecule albumin) extravasation, and hematoxylin-eosin staining h

154 aining serum and exosome proteins, including albumin, fetuin-A, apolipoprotein-A1, alkaline phosphata

155 Additionally, we find that human albumin follows a domain associated unfolding pathway, a

156 tion, temperature, and addition of serum and albumin for broth methods.

157 assemble in vivo from AlbiVax and endogenous albumin for efficient vaccine delivery and potent cancer

158 Therefore, the inhibition of AGE-albumin from activated macrophages could be a successful

159 Taken together, AGE-albumin from activated macrophages is critical for both

160 neutrophils after stimulation with purified albumin from SAH patient plasma.

161 hy neutrophils after treatment with purified albumin from the study groups.

162 advanced glycation end-product-albumin (AGE-albumin) from activated macrophages is critical in both

163 h as glycated hemoglobin (HbA1c) or glycated albumin (GA) in the blood, are essential indicators of g

164 ber 3 alpha (hREG3A) in hepatocytes, via the albumin gene promoter.

165 amascena and Nigella arvensis, including the albumin, globulin, glutein-1, glutein-2 and prolamin fra

166 ic effect; e.g. reduced bilirubin levels and albumin/globulin ratio.

167 Female gender, baseline albumin >/=3.5 g/dL, baseline total bilirubin </=1.2 mg/

168 alized adults in the United States receiving albumin has increased, with marked, and currently unexpl

169 solved diagnostics using specific IgE to 2 S albumins has shown to be a valuable new option in diagno

170 y of measuring plasma creatinine and urinary albumin, has been almost entirely focused on the glomeru

171 post-adsorption of human serum:bovine serum albumin (HS:BSA) mixtures onto the folic acid modified s

172 % dimethyl sulfoxide (DMSO), 15% human serum albumin (HSA) and 0.1% hyaluronans.

173 l structure for determination of human serum albumin (HSA) are designed and fabricated.

174 C1, and C2 domains presented as human serum albumin (HSA) fusion proteins.

175 The label-free detection of human serum albumin (HSA) in aqueous buffer is demonstrated using a

176 SMA and appropriate affinity for human serum albumin (HSA) may demonstrate a higher therapeutic index

177 tor of Abeta self-association is human serum albumin (HSA), which binds approximately 90% of plasma A

178 nusually long serum half-life of human serum albumin (HSA).

179 Furthermore, the amount of recycled albumin in cell culture media corresponded to FcRn-bindi

180 embrane transporters, association with serum albumin in circulatory and extracellular spaces, and ass

181 IR probe (CyG) for precise quantification of albumin in different biofluids and liver targeted in viv

182 include surfactant proteins in lung alveoli, albumin in liver parenchyma, and lipase in the stomach l

183 r visually indistinguishable placebo of 0.1% albumin in saline on days 1 and 22 after randomization.

184 lipid moiety (siRNA-L2), which rapidly binds albumin in situ.

185 and increased intracellular accumulation of albumin in the hepatocyte.

186 nd increased apparent solute permeability to albumin in the same vessels in a time-dependent manner,

187 cific conclusions regarding the unfolding of albumins in the gas phase, as well as more general infer

188 We have found that albumin, in the presence of physiological concentrations

189 me and all 17 disulfide bonds in human serum albumin, including nested disulfide bonds and motifs of

190 HIF-1alpha shRNA blocked albumin-induced changes in these EMT markers as well.

191 In vitro, we showed RTN1A mediates albumin-induced ER stress and apoptosis in human podocyt

192 ce HIF-1alpha level significantly attenuated albumin-induced increases in TIMP-1 and collagen-I level

193 sted the hypothesis that HIF-1alpha mediates albumin-induced profibrotic effect in cultured renal pro

194 s achieved by pharmacologic blockade of FcRn-albumin interactions with monoclonal antibodies or pepti

195 results provide an unprecedented view of how albumin interacts with Abeta and illustrate the potentia

196 We found that cellular albumin internalization was proportional to FcRn express

197 the physiologic release of newly synthesized albumin into the basal milieu.

198 e main function of hepatic FcRn is to direct albumin into the circulation, thereby also increasing he

199 erthermia induced a 30-40% increase in Alexa-Albumin into the tumor micro-environment 24 h after trea

200 eneral unfolding pathway of low charge state albumin ions is largely unaffected by changes in primary

201 Albumin is a potent scavenger of reactive oxygen species

202 The response to albumin is not mediated through regulation of ACT at the

203 Albumin is the most abundant plasma protein involved in

204 ociation constant for Zn(2+) and human serum albumin (Kd = (5.62 +/- 0.93) x 10(-7) M) under physiolo

205 sulted in sustained improvement of the serum albumin level and symptoms in 3 patients, temporary impr

206 level than men, and stratification by serum albumin level attenuated sex differences in the age grou

207 eatment with IVIG (2 g/kg), the median serum albumin level decreased to 3.7 g/dL (interquartile range

208 82 g/L (reference range, 66-81 g/L), a serum albumin level of 39.3 g/L (reference range, 40.2-47.6 g/

209 Women had a significantly lower serum albumin level than men, and stratification by serum albu

210 Before treatment, the median serum albumin level was 4.2 g/dL (interquartile range, 3.8-4.5

211 ferences in health status reflected by serum albumin level.

212 Lymphatic embolization led to improved albumin levels and relief of symptoms.

213 unlike normal Fc interactions and how serum albumin levels are unaffected by DX-2507 binding.

214 hether there is an association between serum albumin levels, a widely used and relatively easily meas

215 ugation of fatty acid, a natural human serum albumin ligand, to a therapeutic protein/peptide was dev

216 APAP-induced liver injury through increased albumin loss into the bile and increased intracellular a

217 range, 3.8-4.5 g/dL), with hypoalbuminemia (albumin, <3.5 g/dL) in 20 (12.8%) of 156 patients.

218 Because the hemin-doped serum albumin mats have both biocompatibility and fabrication

219 INTERPRETATION: Terlipressin with albumin might reduce short-term mortality compared with

220 In this system, albumin nanoparticles (Alb NPs) were prepared from inher

221 seconds to hours after injecting gold-tagged albumin, negatively charged gold nanoparticles, and stab

222 5% of model biochemical species (human serum albumin, neurotensin, creatinine, glycine, and alanine)

223 H prediction risk score PANWARDS (platelets, albumin, no congestive heart failure, warfarin, age, rac

224 ide bridging to maintain conformation (e.g., albumins, nonspecific lipid transfer proteins, saposins,

225 MSB0010853 is cross-reactive with HER3 and albumin of mouse origin.

226 Exposing human podocytes to albumin overload prompted an increase in CUBILIN, AMNION

227 with SAH, there is a significant increase in albumin oxidation, and albumin acts as a pro-oxidant; th

228 SAH-albumin showed the highest albumin oxidative state (P < 0.05) and prominent alterat

229 reversed lysosomal dysfunction and restored albumin permselectivity.

230 d to play a central role in maintaining high albumin plasma levels through a cellular recycling pathw

231 estingly, unusual napin-type 2S seed storage albumin precursors in sunflowers contain a sequence that

232 binding of biopharmaceuticals to human serum albumin protects against enzymatic degradation and renal

233 b release from a nanoshell-based human serum albumin protein host complex resulted in increased cance

234 The C-reactive protein/albumin ratio (CAR) has been shown to play a significant

235 Albumin re-uptake is a receptor-mediated pathway located

236 Impaired albumin reabsorption by proximal tubular epithelial cell

237 bing fundamental mechanisms of intracellular albumin recycling and the possibility to tune albumin-ba

238 ry, quantitative confocal microscopy, and an albumin-recycling assay.

239 Furthermore, albumin reduced the level of hydroxylated HIF-1alpha, in

240 ed by RP-HPLC were observed in glutein-2 and albumin, respectively, for both species.

241 RPS-027 shows dual targeting to PSMA and albumin, resulting in a high tumor uptake, highly favora

242 At 12 months, INR and albumin returned to baseline.

243 of P. aeruginosa in albumin-depleted versus albumin-rich infection sites and an understanding of the

244 ositive co-protein effects with bovine serum albumin, (S-)ovalbumin, egg white, whole egg, defatted e

245 o the lysosomes, suggestive of FcRn-directed albumin salvage from lysosomal degradation.

246 , anti-CD20) are non-covalently bound to the albumin scaffold of nab-paclitaxel (ABX).

247 ss into the bile and increased intracellular albumin scavenging of reactive oxygen species.

248 ngth of end-stage renal disease, hemoglobin, albumin, selected comorbidities, race and type of insura

249 The addition of albumin, serum, and lung surfactant was studied by BMD.

250 le effect of this additive on the binding to albumin should be taken into consideration.

251 SAH-albumin showed the highest albumin oxidative state (P <

252 A minimum mass ratio of about 130 for albumin:silver nanoparticles (40 nm) was required for st

253 Albumin-sized particles permeate extensively into the la

254 ood (WB); and (3) acellular buffered dextran-albumin solution (analogous to STEEN solution).

255 as superior to both RBC and buffered dextran-albumin solution for extended lung preservation in a swi

256 on (IgPro20) weekly versus placebo (2% human albumin solution) for maintenance treatment for 24 weeks

257 pression of the above-mentioned genes in SAH-albumin-stimulated healthy neutrophils was comparable wi

258 n structures of native-like cations of serum albumin, streptavidin, avidin, and alcohol dehydrogenase

259 However, modifications in albumin structure may reduce its antioxidant properties

260 e data reveal the immense promise of in situ albumin targeting for development of translational, carr

261 by the selective modification of recombinant albumin that displays 17 structurally relevant disulfide

262 mance status (PS), C-reactive protein (CRP), albumin, the nutritional risk index, daily energy intake

263 ytes in vitro are committed to internalizing albumin through a receptor-mediated mechanism even after

264 ") had the smallest size and the most native albumin, thus showing the most favorable cell interactio

265 853 contains a third HER3 epitope that binds albumin to extend its circulation time.

266 Treatment of mice with lipidated albumin to induce proteinuria caused a decrease in the p

267 iaturized plasma exchange to deliver labeled albumin to tissues in live mice, and we demonstrate that

268 e subgroup of patients with baseline urinary albumin-to-creatinine ratio >/=30 mg/g, urinary albumin-

269 GFR<60 ml/min per 1.73 m(2) [n=832] or urine albumin-to-creatinine ratio >30 mg/g [n=577]).

270 129 mice exhibited a substantial increase in albumin-to-creatinine ratio (ACR) and serum creatinine l

271 associations of creatinine-based eGFR, urine albumin-to-creatinine ratio (ACR), and dipstick proteinu

272 Here, we report urinary albumin-to-creatinine ratio (UACR) data for the pooled e

273 tions between urine albumin excretion (urine albumin-to-creatinine ratio [UACR]) and genomic regions

274 arameters (glomerular filtration rate, urine albumin-to-creatinine ratio and urine protein-to-creatin

275 umin-to-creatinine ratio >/=30 mg/g, urinary albumin-to-creatinine ratio decreased more with canaglif

276 The urine albumin-to-creatinine ratio genome-wide association scan

277 odels for demographics, baseline eGFR, urine albumin-to-creatinine ratio, comorbidity, and measures o

278 anges in VO2 peak, kidney function, or urine albumin-to-creatinine ratio.

279 biased genome-wide association scan of urine albumin-to-creatinine ratios.

280 d 1287 with values in the upper third of the albumin-to-creatinine ratios; 443 were randomly assigned

281 9.3 g/L (reference range, 40.2-47.6 g/L), an albumin-to-globulin ratio (a test showing relative amoun

282 ment, intracellular pathway, and kinetics of albumin trafficking by flow cytometry, quantitative conf

283 intracellular ROS levels were highest in SAH-albumin-treated neutrophils (P < 0.05).

284 hypothesized that Cav-1 may be critical for albumin uptake in tumors and perhaps determine their res

285 invaginations important for transendothelial albumin uptake.

286 trol or silencing of ORAI expression impairs albumin uptake.

287 albumin use were appropriate indication for albumin use (odds ratio, 65.220; 95% CI, 62.459-68.103);

288 Albumin use varied geographically being lowest with no i

289 Factors independently associated with albumin use were appropriate indication for albumin use

290 increase after 1 h for the high FcRn-binding albumin variant compared with wild-type albumin.

291 al changes were induced by the serum protein albumin via TGFbeta signaling in primary astrocytes.

292 fferent biofluids and liver targeted in vivo albumin visualization is demonstrated.

293 Exposure of a naive brain to albumin was sufficient to induce the transcriptional and

294 e-water distribution coefficients (log Dmw), albumin-water distribution coefficients (log DBSAw), and

295 s inhibited by physiological levels of serum albumin, which appears to bind and sequester some homose

296 g two promising candidate genes AAP8 and 2 S albumin, which might contribute to the high level of WSP

297 like albumin with low FcRn-binding affinity, albumin with high FcRn-binding affinity was directed les

298 Unlike albumin with low FcRn-binding affinity, albumin with hig

299 binding site, HSA Peptide 40, on human serum albumin with nanomolar affinity for all three monoclonal

300 use of wild-type and engineered recombinant albumins with either decreased or increased FcRn affinit